Thyroid Function Abnormalities in HIV-Infected Patients
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Abnormal thyroid function test results are common among human immunodeficiency virus (HIV)-infected patients. Although the prevalence of overt thyroid disease does not appear to be significantly increased in HIV-infected patients, compared with the general population, specific patterns of abnormal thyroid function test findings are more frequently identified among HIV-infected patients. Among patients with advanced acquired immunodeficiency syndrome, nonthyroidal illness (i.e., euthyroid sick syndrome) is common. During antiretroviral therapy, the prevalence of 2 generally asymptomatic conditions (subclinical hypothyroidism, which is characterized by isolated elevated thyroid-stimulating hormone levels, and isolated low free thyroxine levels) is increased. In addition, Graves disease, which is marked by low thyroid-stimulating hormone and elevated thyroxine levels, may occur during immune reconstitution. Testing for thyroid disease among symptomatic patients should begin with measurement of the thyroid-stimulating hormone level. However, there is insufficient evidence to recommend routine thyroid screening of asymptomatic HIV-infected individuals. This review summarizes the current evidence regarding the optimal laboratory evaluation of thyroid function; highlights the causes, presentation, and treatment of thyroid dysfunction in HIV-infected patients; and discusses the controversies regarding screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease
(2003) · Thyroid · doi:10.1089/105072503321086962 · Cited by 1,212
Pearce, E. N., Farwell, A. P., & Braverman, L. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021194 · Cited by 878
Roberts, C. G., & Ladenson, P. W. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15696-1 · Cited by 567
Bunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 1×
“The weight of clinical evidence reveals no improvement in symptoms, including mood and cognitive function, when the synthetic T3 analogue (liothyronine) is added to levothyroxine therapy [16, 17].”
BackgroundThe Evidence for a Narrower Thyrotropin Reference Range Is Compelling
Wartofsky, L., & Dickey, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0455 · Cited by 424
Treatment of Hypothyroidism with Combinations of Levothyroxine plus Liothyronine
Escobar-Morreale, H. F., Botella-Carretero, J. I., del Rey, F. E., & de Escobar, G. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0184 · Cited by 160
The clinical impact of the thyrotropin-releasing hormone test
FAGLIA, G. (1998) · Thyroid · doi:10.1089/thy.1998.8.903 · Cited by 91
Dramatic interaction between levothyroxine and lopinavir/ritonavir in a HIV-infected patient
Touzot, M., Beller, C. L., Touzot, F., Louet, A. L.-L., & Piketty, C. (2006) · AIDS · doi:10.1097/01.aids.0000226969.96880.3c · Cited by 33
Cited by
Viruses and thyroiditis: an update
Desailloud, R., & Hober, D. (2009) · Virology Journal · doi:10.1186/1743-422x-6-5 · Cited by 464
Moura Neto, A., & Zantut-Wittmann, D. E. (2016) · International Journal of Endocrinology · doi:10.1155/2016/2157583 · Cited by 91
Immune reconstitution syndrome and the thyroid
Weetman, A. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.07.003 · Cited by 87
Rasul, S., Delapenha, R., Farhat, F., Gajjala, J., & Zahra, S. M. (2011) · AIDS Research and Treatment · doi:10.1155/2011/743597 · Cited by 40
“Among individuals infected with HIV, 1%-2% might experience clinically apparent thyroid disease, and 35% may have subtle defects in thyroid function test findings [12].”
Association between antiretrovirals and thyroid diseases: a cross-sectional study
Silva, G. A. R. D., Andrade, M. C. T., Sugui, D. D. A. S., Nunes, R. F., Pinto, J. F. D. C., Silva, W. D. A. E., Ferry, F. R. D. A., Azevedo, M. C. V. M. D., & Motta, R. N. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000023 · Cited by 37
Edmunds, M. R., Mellington, F., Ford, R. L., Torlinska, B., Manavi, K., & Boelaert, K. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3544 · Cited by 14
Probable interaction between levothyroxine and ritonavir: case report and literature review
Sahajpal, R., Ahmed, R. A., Hughes, C. A., & Foisy, M. M. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160200 · Cited by 13
Metadata
- Authors
- Mayer, K. H., Hoffmann, C. J., & Brown, T. T.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-08-15
- Volume
- 45
- Issue
- 4
- Pages
- 488-494
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2156876812
- Cited by
- 132
- References
- 9
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.